Management of asthma in young children
Related Experiment Video
Updated: Sep 29, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
1Pediatric Pulmonology, Baylor College of Medicine, 6621 Fannin MC 1040.00, Houston, TX 77030, USA. mmsockri@texaschildrenshospital.org
Insights
Managing childhood asthma effectively involves pharmacotherapy, education, and environmental control to minimize symptoms and improve quality of life. Key strategies include smoke-free environments and personalized asthma action plans.
Area of Science:
- Pediatrics
- Pulmonology
- Allergy & Immunology
Background:
- Childhood asthma presents significant morbidity and reduced quality of life.
- Asthma severity varies, and even children who outgrow it can experience recurrent symptoms.
- Primary prevention via environmental control has shown limited success, but smoke-free environments offer benefits.
Purpose of the Study:
- To outline optimal management strategies for pediatric asthma.
- To emphasize the importance of pharmacotherapy, education, and environmental control.
- To guide physicians in providing comprehensive asthma care for children.
Main Methods:
- Review of current asthma management guidelines for children.
- Emphasis on pharmacotherapy including bronchodilators and anti-inflammatory medications.
- Focus on patient education, environmental control, and self-management training.
Main Results:
- Appropriate pharmacotherapy, education, and environmental control can minimize asthma-related problems.
- Avoidance of passive tobacco smoke exposure is crucial for prevention.
- Regular review of technique, compliance, and provision of asthma action plans are essential.
Conclusions:
- Effective asthma management requires a multi-faceted approach.
- Physicians should partner with families to empower self-management.
- Personalized asthma action plans are vital for symptom monitoring and medication use.
Abstract:
Asthma and recurrent airway symptoms in a young child can result in significant morbidity and reduced quality of life. There is significant variability in asthma severity. Even for those who will "outgrow" asthma, regular problems can be minimized with appropriate pharmacotherapy, education, and environmental control. Success with primary prevention through environmental control for children at high risk for asthma has been limited. Avoidance of passive tobacco smoke exposure has primary and secondary prevention benefits. An inhaled short-acting bronchodilator should be available for use as needed. Patients with regular symptoms should receive maintenance anti-inflammatory medication. Add-on therapy can be considered for those with inadequate control on inhaled corticosteroid. Physicians should regularly review drug delivery technique and compliance and provide all patients with a written asthma action plan to guide symptom monitoring and medication use. Physicians should also establish a partnership with the child and family, providing self-management training to enhance skills and confidence.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
First, in...
01:29Asthma-I: Introduction
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: